- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Synonyms :
Class :
when both drugs are combined, there may be an increase in qtc interval
QT-prolonging Strong may enhance the QTc-prolonging effect of delamanid
may enhance the QTc-prolonging effect of Fluorouracil Products
may increase the CNS depressant effect
may increase the CNS depressant effect
may have an increased QTc-prolonging effect when combined with domperidone
may have an increased CNS depressive effect when combined with CNS depressants
CNS depressants may have an increased CNS depressive effect when combined with flunitrazepam
may have an increased CNS depressant effect when combined with dexmedetomidine
may have an increased CNS depressant effect when combined with CNS depressants
may increase the CNS depressant effect of CNS depressants
may have an increased QTc-prolonging effect when combined with astemizole
may have an increased QTc-prolonging effect when combined with bedaquiline
may have an increased QTc-prolonging effect when combined with chloroquine
may have an increased QTc-prolonging effect when combined with chlorpromazine
may have an increased QTc-prolonging effect when combined with cisapride
may have an increased QTc-prolonging effect when combined with clofazimine
may have an increased QTc-prolonging effect when combined with QT-prolonging agents
may have an increased QTc-prolonging effect when combined with clozapine
may have an increased QTc-prolonging effect when combined with dasatinib
hydroxyzine: they may increase the CNS depressant effect of CNS Depressants
lemborexant: they may increase the CNS depressant effect of CNS Depressants
may have an increased hypotensive effect when combined with apomorphine
nalmefene: they may decrease the therapeutic effect of Opioid Agonists
may increase the CNS depressant effect of CNS Depressants
may increase the CNS depressant effect of Buprenorphine
antiemetics increase the hypotensive effect of apomorphine
antiemetics increase the hypotensive effect of apomorphine
antiemetics increase the hypotensive effect of apomorphine
antiemetics increase the hypotensive effect of apomorphine
when used together, entrectinib and apomorphine both increase the QTc interval
when used together, encorafenib and apomorphine both increase the QTc interval
when both drugs are combined, there may be increase in both increase QTc interval arsenic trioxide
when both drugs are combined, there may be increase in both increase QTc interval arsenic trioxide
antiemetics increase the hypotensive effect of apomorphine
antiemetics increase the hypotensive effect of apomorphine
antiemetics increase the hypotensive effect of apomorphine
may enhance the QTc-prolonging effect of Nilotinib
may increase the QTc interval when combined
azelastine/fluticasone intranasal
may increase the CNS depressant effect
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of orphenadrine
it increases the effect of CNS depressants
CNS depressants increase the effect of paraldehyde
it increases the effect of CNS depressants
may have an increased CNS depressant effect when combined with CNS depressants
may have an increased CNS depressant effect when combined with flunarizine
may have an increased QTc-prolonging effect when combined with flupentixol
may have an increased QTc-prolonging effect when combined with levoketoconazole
It may enhance QTc interval when combined with pentamidine
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
it may enhance the QTc-prolonging effect of QT-Prolonging Anesthetics
CNS Depressants may enhance the CNS depressant effect of Opioid agonists
CNS Depressants may enhance the CNS depressant effect of Opioid agonists
CNS Depressants may enhance the CNS depressant effect of Opioid agonists
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may enhance the CNS depressant effect of Opioid Agonists
may enhance the CNS depressant effect of Opioid Agonists
may enhance the CNS depressant effect of Opioid Agonists
may enhance the CNS depressant effect of Opioid Agonists
It may enhance sedation when combined with tramadol
when both drugs are combined, both increase the QTC interval
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased QTC interval
when both drugs are combined, there may be an increased QTC interval
lisuride may enhance the CNS depressant effect of CNS Depressants
it increases the effect of CNS depressants
it increases the effect of CNS depressants
when combined, it may increase sedation
may increase the QTc interval
when combined, it may increase sedation
glycopyrrolate inhaled and formoterol
may increase the QTc interval when combined
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the adverse/toxic effect of other CNS depressants
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may enhance the QTc-prolonging effect of other QT-prolonging Agents
may increase the QTc prolonging effect of QTc prolonging agents
may have an increased QTc-prolonging effect when combined with QT-prolonging antipsychotics
may have an increased CNS depressant effect when combined with brexanolone
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
may have an increased CNS depressive effect when combined with CNS depressants
it increases the effect of CNS depressants
CNS depressants increase the efficacy of cannabinoid-containing products
CNS depressants increase the efficacy of cannabinoid-containing products
it increases the effect of CNS depressants
it increases the effect of CNS depressants
may increase the toxic effect of CNS depressants
lofexidine: they may increase the CNS depressant effect of CNS Depressants
pramipexole: they may increase the sedative effect of CNS Depressants
it increases the effect of CNS depressants
CNS depressants increase the effect of zolpidem
it increases the effect of CNS depressants
CNS depressants increase the effect of oxycodone